» Articles » PMID: 6188315

FITC-Dextrans As Tracers for Macromolecular Movements in the Nervous System. A Freeze-drying Method for Dextrans of Various Molecular Sizes Injected into Normal Animals

Overview
Specialty Neurology
Date 1983 Jan 1
PMID 6188315
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

A freeze-drying method has been developed by which fluorescein thiocarbamoyl dextrans (FITC-dextrans) can be localized in thin sections from nervous tissue and muscles. Labelled dextrans with molecular weights of 3,000, 20,000, 70,000 and 150,000 were injected intravenously (i.v.) into golden hamsters and samples from brain, trigeminal ganglia and sciatic nerves were examined 30 min or 4 h later. For comparison experiments were also carried out in mice and some other tracers were tested as well. The dextrans did not pass out of blood vessels in cerebral cortex and white matter. The blood vessels in the trigeminus ganglion were permeable to all of the tested compounds, i.e. even the FITC-dextran with mol.wt. 150,000. Little, if any, i.v. injected dextran could be detected in the endoneurium of sciatic nerve fascicles. Even very high concentrations of dextrans (mol.wt. 3,000 and 150,000) injected around the sciatic nerves did not penetrate the perineurium of the sciatic nerve. As compared with other tracers dextrans have the advantage that they can be obtained in a wide range of molecular sizes. With the proposed technique presented at the end of this article they can be used for studies on vascular permeability in deep tissue like brain, ganglia and peripheral nerve. The use of these tracers will probably be particularly advantageous in investigations concerning the etiology of edematous conditions.

Citing Articles

Brain-to-blood transport of fluorescein in vitro.

Schoknecht K, Eilers J Sci Rep. 2024; 14(1):25572.

PMID: 39462032 PMC: 11513102. DOI: 10.1038/s41598-024-77040-2.


Hypergravity Increases Blood-Brain Barrier Permeability to Fluorescent Dextran and Antisense Oligonucleotide in Mice.

Dubayle D, Vanden-Bossche A, Peixoto T, Morel J Cells. 2023; 12(5).

PMID: 36899870 PMC: 10000817. DOI: 10.3390/cells12050734.


Biology of the human blood-nerve barrier in health and disease.

Ubogu E Exp Neurol. 2020; 328:113272.

PMID: 32142802 PMC: 7145763. DOI: 10.1016/j.expneurol.2020.113272.


The Human Blood-Nerve Barrier Transcriptome.

Palladino S, Helton E, Jain P, Dong C, Crowley M, Crossman D Sci Rep. 2017; 7(1):17477.

PMID: 29234067 PMC: 5727190. DOI: 10.1038/s41598-017-17475-y.


An in vivo mechanism for the reduced peripheral neurotoxicity of NK105: a paclitaxel-incorporating polymeric micellar nanoparticle formulation.

Nakamura I, Ichimura E, Goda R, Hayashi H, Mashiba H, Nagai D Int J Nanomedicine. 2017; 12:1293-1304.

PMID: 28243090 PMC: 5317268. DOI: 10.2147/IJN.S114356.


References
1.
Olsson Y . Studies on vascular permeability in peripheral nerves. IV. Distribution of intravenously injected protein tracers in the peripheral nervous system of various species. Acta Neuropathol. 1971; 17(2):114-26. DOI: 10.1007/BF00687487. View

2.
Hulstrom D, Svensjo E . Intravital and electron microscopic study of bradykinin-induced vascular permeability changes using FITC-dextran as a tracer. J Pathol. 1979; 129(3):125-33. DOI: 10.1002/path.1711290304. View

3.
Oldfors A . Macrophages in peripheral nerves. An ultrastructural and enzyme histochemical study on rats. Acta Neuropathol. 1980; 49(1):43-9. DOI: 10.1007/BF00692218. View

4.
van Deurs B . Structural aspects of brain barriers, with special reference to the permeability of the cerebral endothelium and choroidal epithelium. Int Rev Cytol. 1980; 65:117-91. DOI: 10.1016/s0074-7696(08)61960-9. View

5.
Schroder U, Arfors K, TANGEN O . Stability of fluorescein labeled dextrans in vivo and in vitro. Microvasc Res. 1976; 11(1):57-66. View